Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Incremental employee health benefit costs, absence days, and turnover among employees with ADHD and among employees with children with ADHD.

Kleinman NL, Durkin M, Melkonian A, Markosyan K.

J Occup Environ Med. 2009 Nov;51(11):1247-55. doi: 10.1097/JOM.0b013e3181bca68c.

PMID:
19858744
2.

The economic impact of bipolar disorder in an employed population from an employer perspective.

Gardner HH, Kleinman NL, Brook RA, Rajagopalan K, Brizee TJ, Smeeding JE.

J Clin Psychiatry. 2006 Aug;67(8):1209-18.

PMID:
16965198
3.

Annual incremental health benefit costs and absenteeism among employees with and without rheumatoid arthritis.

Kleinman NL, Cifaldi MA, Smeeding JE, Shaw JW, Brook RA.

J Occup Environ Med. 2013 Mar;55(3):240-4. doi: 10.1097/JOM.0b013e318282d310.

PMID:
23471034
4.

Benefits for employees with children with ADHD: findings from the Collaborative Employee Benefit Study.

Perrin JM, Fluet C, Kuhlthau KA, Anderson B, Wells N, Epstein S, Allen D, Tobias C.

J Dev Behav Pediatr. 2005 Feb;26(1):3-8.

PMID:
15718875
5.

The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US.

Ivanova JI, Birnbaum HG, Samuels S, Davis M, Phillips AL, Meletiche D.

Pharmacoeconomics. 2009;27(8):681-91. doi: 10.2165/11314700-000000000-00000.

PMID:
19712010
6.

Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder.

Secnik K, Swensen A, Lage MJ.

Pharmacoeconomics. 2005;23(1):93-102.

PMID:
15693731
7.

Health benefit costs and absenteeism due to insomnia from the employer's perspective: a retrospective, case-control, database study.

Kleinman NL, Brook RA, Doan JF, Melkonian AK, Baran RW.

J Clin Psychiatry. 2009 Aug;70(8):1098-104. doi: 10.4088/JCP.08m04264.

PMID:
19758521
8.

Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.

Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Muriel AC, Frank RG.

Arch Gen Psychiatry. 2005 Apr;62(4):435-41.

9.

Economic implications of treatment-resistant depression among employees.

Greenberg P, Corey-Lisle PK, Birnbaum H, Marynchenko M, Claxton A.

Pharmacoeconomics. 2004;22(6):363-73.

PMID:
15099122
10.

Persistence and adherence with urinary antispasmodic medications among employees and the impact of adherence on costs and absenteeism.

Kleinman NL, Odell K, Chen CI, Atkinson A, Zou KH.

J Manag Care Spec Pharm. 2014 Oct;20(10):1047-56.

11.

Absenteeism and health-benefit costs among employees with MS.

Brook RA, Rajagopalan K, Kleinman NL, Melkonian AK.

Curr Med Res Opin. 2009 Jun;25(6):1469-76. doi: 10.1185/03007990902905468.

PMID:
19422277
12.

The impact of hepatitis C virus infection on work absence, productivity, and healthcare benefit costs.

Su J, Brook RA, Kleinman NL, Corey-Lisle P.

Hepatology. 2010 Aug;52(2):436-42. doi: 10.1002/hep.23726.

PMID:
20683943
13.

The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm.

Kessler RC, Lane M, Stang PE, Van Brunt DL.

Psychol Med. 2009 Jan;39(1):137-47. doi: 10.1017/S0033291708003309. Epub 2008 Apr 21.

PMID:
18423074
14.

Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.

Wu EQ, Birnbaum HG, Zhang HF, Ivanova JI, Yang E, Mallet D.

J Manag Care Pharm. 2007 Sep;13(7):561-9.

15.

Direct and indirect costs among employees with diabetic retinopathy in the United States.

Lee LJ, Yu AP, Cahill KE, Oglesby AK, Tang J, Qiu Y, Birnbaum HG.

Curr Med Res Opin. 2008 May;24(5):1549-59. doi: 10.1185/030079908X297303 . Epub 2008 Apr 15.

PMID:
18416887
16.

Economic burden of gouty arthritis attacks for employees with frequent and infrequent attacks.

Lynch W, Chan W, Kleinman N, Andrews LM, Yadao AM.

Popul Health Manag. 2013 Apr;16(2):138-45. doi: 10.1089/pop.2012.0057. Epub 2012 Oct 31.

PMID:
23113634
17.
18.
19.

The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database.

Joish VN, Donaldson G, Stockdale W, Oderda GM, Crawley J, Sasane R, Joshua-Gotlib S, Brixner DI.

Curr Med Res Opin. 2005 Apr;21(4):535-44.

PMID:
15899102
20.

Evaluation of a comprehensive employee wellness program at an organization with a consumer-directed health plan.

Burton WN, Chen CY, Li X, Schultz AB, Kasiarz D, Edington DW.

J Occup Environ Med. 2014 Apr;56(4):347-53. doi: 10.1097/JOM.0000000000000121.

PMID:
24709759

Supplemental Content

Support Center